Precise Infliximab Exposure and Pharmacodynamic Control | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Precise Infliximab Exposure and Pharmacodynamic Control	Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder	Recruiting	Phase 2 / Phase 3	2026-05-05		NCT05660746

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Children's Hospital Medical Center, Cincinnati	229
Janssen Scientific Affairs, LLC	37
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's Hospital of Los Angeles	Los Angeles	United States	56
Children's Specialty Group	Norfolk	United States	2
Cincinnati Children's Hospital	Cincinnati	United States	66
Cleveland Clinic Children's Hospital	Cleveland	United States	4
Lucile Packard Children's Hospital Stanford	Palo Alto	United States	20
Medical College of Wisconsin, Children's of Wisconsin	Milwaukee	United States	1
Nationwide Children's Hospital	Columbus	United States	309
Nemours Children's Health System-Jacksonville	Jacksonville	United States	1
Nemours Children's Health System-Wilmington	Wilmington	United States	1
Rady Children's Hospital San Diego	San Diego	United States	24
Riley Hospital for Children	Indianapolis	United States	134